Veru Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$2.48

+0.07 (+2.90%)

As of Sep 21, 5:16 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +1,411.3% upside

Low Target $21.76

Average Target $37.48

High Target $51.92

Current Price $2.48

Current
$2.48

Target
$37.48

$21.76 $37.48 avg $51.92

Scenario Analysis

Bear Case

$21.76

777.4%

Low target

Base Case

$37.48

+1,411.3%

Avg target

Bull Case

$51.92

+1,993.5%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$7.33

-66.2% from high

52-Week Low

$2.05

+21.0% from low

Target vs 52W High

$37.48

+411.3% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+14.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.2%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+6.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+22.2%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+178.7%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+194.2%